This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AOL, Thoratec, Walgreen's, WebMD, More

NEW YORK (TheStreet) -- RATINGS CHANGES

AOL (AOL) was upgraded to buy at Cantor Fitzgerald. $50 12-month price target. Business fundamentals are improving, Cantor Fitzgerald said.

Atmel (ATML) was downgraded to neutral at Bank of America/Merrill Lynch. $9 12-month price target. The company has muted growth prospects, BofA/Merrill said.

Esterline (ESL) was upgraded to buy from neutral at Goldman Sachs. Consensus estimates are too low and the company is attractively valued, Goldman said. $140 12-month price target.

Must Read: Chevron, Exxon Highlight Up and Down Year in Oil Sector

First Security (FSGI) was upgraded to hold at TheStreet Ratings.

Nu Skin (NUS) was downgraded to neutral from overweight at J.P. Morgan. $50 12-month price target. Risk still remains in the shares, said J.P. Morgan.

Ralph Lauren (RL) was upgraded to outperform from neutral at Credit Suisse. $180 12-month price target. The company is seeing higher retail demand and margins are likely to rebound in the second half, Credit Suisse said.

Telefonica (TEF) was upgraded to buy at TheStreet Ratings.

Thoratec (THOR - Get Report) was downgraded to neutral at Goldman Sachs. $28 12-month price target. The company has limited visibility, said Goldman.

Thoratec (THOR - Get Report) was downgraded to neutral from outperform at Credit Suisse. $27 12-month price target. The company lowered its guidance meaningfully, Credit Suisse said.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
THOR $44.19 -0.11%
WAG $81.65 2.05%
AAPL $126.44 -0.13%
FB $87.28 0.43%
GOOG $523.40 0.30%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs